Cannabis Bioscience International Holdings (CBIH) Income from Continuing Operations (2022 - 2026)

Cannabis Bioscience International Holdings has disclosed Income from Continuing Operations across 5 years of filings, most recently posting 104035.0 for Q1 2026.

• Income from Continuing Operations for Q1 2026 came in at 104035.0, up 31.42% year-over-year; the trailing twelve-month figure through Feb 2026 was 532943.0 (down 76.64% YoY), and the FY2025 annual result was 557627.0, down 12.17% from the prior year.
• Income from Continuing Operations came in at 104035.0 for Q1 2026 at Cannabis Bioscience International Holdings, down from 99107.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 18270.0 in Q2 2024 to a low of 324655.0 in Q1 2023.
• The 5-year median for Income from Continuing Operations is 127871.0 (2025), against an average of 152913.5.
• Across the five-year window, Income from Continuing Operations surged 106.62% in 2024 and plunged 1400.76% in 2025, its largest moves.
• Cannabis Bioscience International Holdings' Income from Continuing Operations stood at 219886.0 in 2022, then jumped by 57.02% to 94512.0 in 2023, then advanced by 27.7% to 68328.0 in 2024, then slumped by 45.05% to 99107.0 in 2025, then fell by 4.97% to 104035.0 in 2026.
• The last three Income from Continuing Operations figures came in at 104035.0 (Q1 2026), 99107.0 (Q4 2025), and 92152.0 (Q3 2025), per Business Quant data.